查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439949

造影剂注射器 - 全球市场回顾、竞争格局、市场预测（2030）

Contrast Media Injectors - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2022年，全球造影剂注射器市场规模将达到11.72亿美元，到2030年将达到15.04亿美元，在2024-2030年的预测期内复合年增长率可能达到4.27%。 该市场呈现显着的市场成长，主要是由于癌症、神经系统、心血管等各种慢性疾病的增加。 此外，人口老化更容易患慢性病、年轻人中不健康和久坐的生活方式氾滥、对微创手术的需求增加、无注射器注射器和剂量记录系统等技术进步以及产品发布。预计主要参与者的申请和批准数量以及投资激增也将对预测期内造影剂注射器的需求产生积极影响。 因此，预计在 2024 年至 2030 年的预测期内，市场将以显着的复合年增长率成长。

造影剂注射器市场动态

根据世界卫生组织 (WHO) (2022) 的情况说明书，2020 年乳癌新发病例为 226 万例，其次是肺癌 221 万例、结直肠癌 193 万例和 1.41 例。前列腺癌100 万例、皮肤癌120 万例、胃癌109 万例。 造影剂注射器用于正确可视化肿瘤的正常和病理解剖结构，并向癌症患者註射显影剂。

在癌症的情况下，可能会出现新的异常血管，这些血管比正常毛细血管更容易渗漏。 在这种情况下，如果透过使用注射器注射显影剂来进行诊断，则使用造影扫瞄仪可以比其他诊断方法更清楚地看到病变。 因此，癌症盛行率的增加最终将增加对造影剂注射器的需求。

心血管疾病被认为是全球第一大死因。 世界卫生组织（2022）的数据显示，2019 年估计有 1,790 万人死于心血管疾病，占全球死亡人数的 32%。 2019 年，因非传染性疾病导致的 1,700 万人过早死亡（70 岁以下）中，38% 死于心血管疾病。 在适当的时间使用诊断影像设备对心血管疾病进行正确的诊断可以降低不断增加的死亡率。 在诊断影像中，在造影剂注射器的帮助下注射显影剂，以正确地显示解剖结构。 因此，它将影响预测期内造影剂注射器的需求。

此外，造影剂注射器取得了多项技术进步，以减少显影剂浪费并自动收集有关患者剂量的数据。 例如，自动注射系统准确地收集所使用的造影剂的量。 供应商使用 EMR 和 PACS 的数据来为患者量身订做剂量。 无注射器注射器就是减少显影剂浪费的进步。 大多数製造商也致力于开发新产品，以减少显影剂浪费并获得竞争优势。 例如，博莱科的智慧型无注射器注射器利用装载到系统中的每一滴造影剂来实现最大效率。 智慧注射器不仅记录注射量，还记录所使用的成像协议并将数据发送到 PACS。 造影剂注射器技术的这些持续技术进步预计将在预测期内推动市场发展。 因此，上述因素将共同推动 2024-2030 年预测期内的整体造影剂注射器市场。

然而，造影剂注射器和耗材的高成本，以及造影剂的副作用，可能会对造影剂注射器市场的成长带来挑战。

造影剂注射器市场在 COVID-19 大流行期间受到显着影响，许多放射科的诊断影像病例数急剧下降。 COVID-19 大流行影响了医疗机构的使用，因为患者被迫等待挽救生命的影像检查。 此外，由于严格的封锁规定的实施，对製造、供应链和劳动力造成干扰，对造影剂注射器的需求受到了影响。 然而，封锁规定的放鬆、资源和供应链的转变、向大众注射疫苗以及患者返回医院和诊断成像中心增加了对造影剂注射器的需求，推动了市场成长。

本报告研究和分析了全球造影剂注射器市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第一章比较介质注射器市场报告简介

第 2 章比较介质注入器市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估

第三章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章造影剂注射器市场主要因素分析

  • 对比介质注射器市场驱动因素
  • 造影剂注射器市场的限制与挑战
  • 造影剂注射器市场机会

第 5 章比较介质注射器市场的波特五力分析

第 6 章 COVID-19 对造影剂注射器市场的影响分析

第七章造影剂注射器市场布局

  • 按产品
    • 喷射系统
    • 消耗品
  • 按註射器类型
    • 单头注射器
    • 双头注射器
    • 无注射器注射器
  • 依用途
    • 辐射
    • 心臟干预
    • 其他
  • 地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第 8 章造影剂注射器市场公司与产品概况

  • GE HealthCare
  • Bracco
  • MEDTRON AG
  • Ulrich GmbH & Co. KG
  • Bayer Pharmaceuticals
  • Nemoto Kyorindo co., Ltd.
  • SINO MDT
  • APOLLO RT Co. Ltd.
  • Shenzhen Seacrown Electromechanical Co., Ltd.
  • HONG KONG MEDI CO LIMITED

第9章KOL浏览量

第 10 章专案方法

第 11 章关于 DelveInsight

第 12 章免责声明与联络我们

Product Code: DIMDCL0630

Contrast Media Injectors Market By Product (Injector Systems [Ct Injector Systems, Mri Injector Systems, And Cardiovascular/Angiography Injector Systems] And Consumables [Tubing, Syringe, And Other]), By Type Of Injectors (Single-Head Injectors, Dual-Head Injectors, And Syringeless Injectors), By Application (Radiology, Interventional Cardiology, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the rising prevalence of chronic diseases across the globe and surging demand of minimally invasive surgeries

The global contrast media injectors market was valued at USD 1,172 million in 2022 and is likely to register a CAGR of 4.27% during the forecast period from 2024 to 2030 to reach USD 1,504 million by 2030. The contrast media injectors market is observing significant market growth primarily owing to the mounting figures of various chronic diseases such as cancers, neurological, and cardiovascular among others. Further, an increase in the geriatric population base prone to chronic diseases, surging unhealthy and sedentary lifestyles among youngsters, increasing demand for minimally invasive surgeries, technological advancements such as syringeless injectors and dose recording systems, increasing product launches and approvals, surging investments by key players, and others will also affect the demand for contrast media injectors positively during the forecast period. Therefore, the market of contrast media injectors is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Contrast Media Injectors Market Dynamics:

According to World Health Organization (WHO) 2022 factsheet, the new cases of breast cancer in 2020 was 2.26 million, followed by lung cancer with 2.21 million cases, colon and rectum cancer reported 1.93 million new cases, prostate cancer with 1.41 million cases, skin cancer - with 1.20 million cases, and stomach cancer with 1.09 million cases, worldwide. Contrast media injectors are used to inject contrast media into cancer patients for proper visualization of normal and pathologic anatomy of tumor.

In case of cancers, new abnormal blood vessels may develop, which tend to be leakier than normal capillaries. In this case, if the contrast media is injected using injectors for diagnosis then the lesion can be much more visible on contrast enhanced scaners as compared to the other diagnosis method. Thus, the increasing prevalence of cancer will ultimately increase the demand for contrast media injectors.

Cardiovascular diseases are considered to be the leading cause of death globally. As per the WHO 2022 data, an estimated 17.9 million people died from cardiovascular disorders in 2019, illustrating 32% of all global deaths. Out of the 17 million premature deaths (under the age of 70 years) due to non-communicable diseases in 2019, 38% of the deaths were caused due to cardiovascular disorders. The increasing mortality can be reduced if proper diagnosis of cardiovascular diseases is done at an apt time using imaging devices. During imaging diagnosis contrast media is injected with the help of contrast media injectors to get proper visualization of the anatomy. Thus, affecting the demand for contrast media injectors during the forecast period.

Further, several advances in contrast media injector technology have been made to reduce contrast media waste and automate data collection about a patient's dose. Automated injector systems, for example, precisely collect the amount of contrast media used. Vendors provide personalized doses to patients by utilizing data from EMR or Picture Archiving and Communication System (PACS). Syringeless injectors are one such advancement in reducing contrast media waste. Also, most of the manufacturers are working on new products to reduce contrast media waste and gain a competitive advantage. For instance, Bracco's smart syringeless injectors that use every drop of contrast loaded into the system for maximum efficiency. Smart injectors record the amount injected as well as the imaging protocol used and transmit the data to the PACS. In contrast to media injector technology, these constant technological advancements are expected to boost the market during the forecast period. Therefore, the factors stated above collectively will drive the overall contrast media injectors market during the forecast period from 2024-2030.

However, the high cost of contrast media injectors and consumables, adverse effects of contrast agents, and others may prove to be challenging factors for contrast media injectors' market growth.

The contrast media injectors market was significantly impacted during the period of COVID- 19 pandemic as the volume of imaging cases in many radiology departments dropped dramatically. The COVID-19 outbreak impacted patients' access to healthcare facilities as the pandemic forced them to wait for lifesaving imaging procedures. Moreover, the demand for contrast media injectors suffered a disgrace owing to the imposition of strict lockdown rules, and disruption in manufacturing, supply chain, and workforce. However, with the ease of lockdown restrictions, the upturn of resources and supply chain, the administration of a vaccine to the public, and the return of patients to hospitals or diagnostic imaging centers, the demand for contrast media injectors increased and is driving the market growth.

Contrast Media Injectors Market Segment Analysis:

Contrast Media Injectors Market by Product (Injector Systems [CT Injector Systems, MRI Injector Systems, and Cardiovascular/Angiography Injector Systems] and Consumables [Tubing, Syringe, and Other]), Type of Injectors (Single-Head Injectors, Dual-Head Injectors, and Syringeless Injectors), Application (Radiology, Interventional Cardiology, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the contrast media injectors market, the CT Injector Systems segment is expected to have a significant revenue share in the year 2023. This is owing to its widespread use in the detection and treatment of vascular disease, cancer, and orthopedic injuries and disorders. Moreover, technological advancements and the launch of new products are further expected to propel the growth of the segment.

CT injectors are expected to grow in popularity as the use of CT systems has increased. During imaging, these CT systems employ a dual-head injector with two syringes for initial and follow-up contrast doses. Major academic institutions and pharmaceutical companies have been engaged in continuous R&D to develop protocols that assist CT users with the advanced capabilities of newer imaging systems.

Furthermore, major players are gradually implementing various strategies, such as collaborative initiatives to remain competitive in the market. For instance, in September 2019, The MedradStellant Flex CT injectable system from Bayer was released. The Stellant Flex system is a user-driven system with little technician training and automation. It provides personalized patient protocols and personalized imaging, as well as flexible capital equipment alternatives through the company's TechCare service.

Also, in May 2022, Bayer Korea started marketing MEDRAD Centargo, a computed tomography (CT) injection medical device, which received approval from the Ministry of Food and Drug Safety in January. Similarly, Ulrich Medical, a German medical technology company, presented a version of its CT motion contrast media injector designed for the American market at the RSNA in Chicago in May 2020. It was approved by the FDA and marketed in collaboration with GE Healthcare.

Therefore, owing to the above-mentioned factors, the demand for CT injector systems surges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global contrast media injectors market during the forecast period.

North America Is Expected To Dominate The Overall Contrast Media Injectors Market:

Among all the regions, North America is expected to dominate global contrast media injectors in the year 2023 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the rising demand for minimally invasive surgeries in the region as the minimally invasive surgical procedures with contrast media injectors deliver high-quality real-time imaging of the surgical site, and ensure that surgeons are treating the appropriate area. Further, the increasing burden of chronic diseases, presence of contrast media injectors manufacturer's hub in the US, rising product launches and approvals, favorable reimbursement scenarios, and others act as supportive factors for the North America contrast media injectors market growth.

For instance, as per the data provided by the American Cancer Society, it is estimated that in 2023, nearly 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States.

According to the CDC data updated in 2022, chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. They also contribute to USD 3.8 trillion in annual healthcare costs. Six in 10 adults in the country have a chronic disease, and four in every 10 have two or more chronic diseases. Additionally, according to Heart Disease & Stroke Statistical Fact Sheet 2020, a minimum of 40,000 infants are expected to be affected yearly by congenital heart defects in the United States. About 25% or 2.4 (per 1,000 live births) require treatment in the first year of an infant's life.

Thus, the increasing prevalence of various chronic diseases will increase the demand for contrast media injectors as these injectors are usually employed during the diagnosis of the above-mentioned diseases. Therefore, the increasing prevalence of chronic diseases will propel the market of contrast media injectors during the forecast period.

Additionally, countries such as the U.S. and Canada have seen an increase in hospital admissions in recent years, as a result of the high occurrence of chronic medical diseases & fatal injuries.

The surging product launches and approvals in the region will in turn propel the overall market. For instance, in July 2022, Ulrich received FDA approval for the ulrichINJECT CT motion. The ulrichINJECT CT motion system consists of the CT motion terminal, CT motion injector, and CT motion tubing system. Also, in November 2022, GE Healthcare and Ulrich Medical announced an agreement to offer a branded multi-dose contrast media injector in the United States.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North America region in the contrast media injectors market.

Contrast Media Injectors Market Key Players:

Some of the key market players operating in the contrast media injectors market include GE HealthCare, Bracco, MEDTRON AG, Ulrich GmbH & Co. KG, Bayer Pharmaceuticals, Nemoto Kyorindo co., Ltd., SINO MDT, APOLLO RT Co. Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., HONG KONG MEDI CO LIMITED, and others.

Recent Developmental Activities in the Contrast Media Injectors Market:

In December 2022, Guerbet and Bracco Imaging announced a global collaboration for Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent.

In December 2022, Qaelum NV announced a strategic partnership with Ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with Ulrich Medical's contrast media injectors to support the needs of hospitals and imaging networks.

Key Takeaways from the Contrast Media Injectors Market Report Study

Market size analysis for current contrast media injectors market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the contrast media injectors market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global contrast media injectors market.

Various opportunities are available for the other competitor in the contrast media injector's market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current contrast media injector's market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for contrast media injector's market growth in the coming future?

Target Audience who can be benefited from this Contrast Media Injectors Market Report Study

Contrast media injectors products providers

Research organizations and consulting companies

Contrast media injectors- related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing, in contrast media injectors

Various end users who want to know more about the contrast media injectors market and the latest technological developments in the contrast media injectors market.

Frequently Asked Questions for the Contrast Media Injectors Market:

1. What are contrast media injectors?

Contrast media injectors (CMI) are devices employed for injecting contrast media into the body to improve the visibility of tissues for medical imaging procedures.

2. What is the global market for contrast media injectors?

The global contrast media injectors market was valued at USD 1,172 million in 2022 and is likely to register a CAGR of 4.27% during the forecast period from 2024 to 2030 to reach USD 1,504 million by 2030.

3. What are the drivers for the global contrast media injectors market?

The contrast media injectors market is witnessing positive market growth owing to the factors such as the increasing demand for minimally invasive surgeries, rising prevalence of chronic disorders, technological advancements and an increasing number of regulatory approvals, increasing product launches and approvals, and others will create an exigency for the contrast media injectors market.

4. Who are the key players operating in the global contrast media injectors market?

Some of the key market players operating in the contrast media injectors market include GE HealthCare, Bracco, MEDTRON AG, Ulrich GmbH & Co. KG, Bayer Pharmaceuticals, Nemoto Kyorindo co., Ltd., SINO MDT, APOLLO RT Co. Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., HONG KONG MEDI CO LIMITED, and others.

5. Which region has the highest share of the contrast media injectors market?

Among all the regions, North America is estimated to amass a significant revenue share in the global contrast media injectors market. This can be ascribed to the rising demand for minimally invasive surgeries, increasing burden of chronic diseases, presence of contrast media injectors manufacturer's hub in the US, rising product launches and approvals, and others act as a supportive factor for the North American contrast media injectors market growth.

Table of Contents

1.Contrast Media Injectors Market Report Introduction

2. Contrast Media Injectors Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Contrast Media Injectors Market Key Factors Analysis

  • 4.1. Contrast Media Injectors Market Drivers
    • 4.1.1. Increasing demand for minimally invasive surgeries
    • 4.1.2. Rising prevalence of chronic disorders
    • 4.1.3. Technological Advancements and Increasing Number of Regulatory Approvals
  • 4.2. Contrast Media Injectors Market Restraints and Challenges
    • 4.2.1. High cost of contrast media injectors and consumables
    • 4.2.2. Adverse effects of contrast agents
  • 4.3. Contrast Media Injectors Market Opportunities
    • 4.3.1. IT-driven platforms for contrast media injectors

5. Contrast Media Injectors Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Contrast Media Injectors Market

7. Contrast Media Injectors Market Layout

  • 7.1. By Product
    • 7.1.1. Injector Systems
      • 7.1.1.1. CT Injector Systems
      • 7.1.1.2. MRI Injector Systems
      • 7.1.1.3. Cardiovascular/Angiography Injector Systems
    • 7.1.2. Consumables
      • 7.1.2.1. Tubing
      • 7.1.2.2. Syringe
      • 7.1.2.3. Other
  • 7.2. By Type of Injectors
    • 7.2.1. Single-head Injectors
    • 7.2.2. Dual-head Injectors
    • 7.2.3. Syringeless Injectors
  • 7.3. By Application
    • 7.3.1. Radiology
    • 7.3.2. Interventional Cardiology
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.1.2. Canada Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.1.3. Mexico Contrast Media Injectors Market in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.2. Germany Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.4. Italy Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.5. Spain Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Contrast Media Injectors Market in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.2. Japan Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.3. India Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.4. Australia Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.5. South Korea Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia Pacific Contrast Media Injectors Market in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.4.2. Africa Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.4.3. South America Contrast Media Injectors Market in USD million (2021-2030)

8. Contrast Media Injectors Market Company and Product Profiles

  • 8.1. GE HealthCare
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Bracco
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. MEDTRON AG
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Ulrich GmbH & Co. KG
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Bayer Pharmaceuticals
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Nemoto Kyorindo co., Ltd.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. SINO MDT
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. APOLLO RT Co. Ltd.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Shenzhen Seacrown Electromechanical Co., Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. HONG KONG MEDI CO LIMITED
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Contrast Media Injectors Market
  • Table 3: Contrast Media Injectors Market Analysis in Global (2021-2030)
  • Table 4: Contrast Media Injectors Market Analysis in Global by Product (2021-2030)
  • Table 5: Contrast Media Injectors Market Analysis in Global by Type of Injectors (2021-2030)
  • Table 6: Contrast Media Injectors Market Analysis in Global by Application (2021-2030)
  • Table 7: Contrast Media Injectors Market Analysis in Global by Geography (2021-2030)
  • Table 8: Contrast Media Injectors Market Analysis in North America (2021-2030)
  • Table 9: Contrast Media Injectors Market Analysis in North America by Country (2021-2030)
  • Table 10: Contrast Media Injectors Market Analysis in the US (2021-2030)
  • Table 11: Contrast Media Injectors Market Analysis in Canada (2021-2030)
  • Table 12: Contrast Media Injectors Market Analysis in Mexico (2021-2030)
  • Table 13: Contrast Media Injectors Market Analysis in Europe (2021-2030)
  • Table 14: Contrast Media Injectors Market Analysis in Europe by Country (2021-2030)
  • Table 15: Contrast Media Injectors Market Analysis in France (2021-2030)
  • Table 16: Contrast Media Injectors Market Analysis in Germany (2021-2030)
  • Table 17: Contrast Media Injectors Market Analysis in the UK (2021-2030)
  • Table 18: Contrast Media Injectors Market Analysis in Italy (2021-2030)
  • Table 19: Contrast Media Injectors Market Analysis in Spain (2021-2030)
  • Table 20: Contrast Media Injectors Market Analysis in the Rest of Europe (2021-2030)
  • Table 21: Contrast Media Injectors Market Analysis in Asia-Pacific (2021-2030)
  • Table 22: Contrast Media Injectors Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 23: Contrast Media Injectors Market Analysis in China (2021-2030)
  • Table 24: Contrast Media Injectors Market Analysis in Japan (2021-2030)
  • Table 25: Contrast Media Injectors Market Analysis in India (2021-2030)
  • Table 26: Contrast Media Injectors Market Analysis in Australia (2021-2030)
  • Table 27: Contrast Media Injectors Market Analysis in South Korea (2021-2030)
  • Table 28: Contrast Media Injectors Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Table 29: Contrast Media Injectors Market Analysis in the Rest of the World (2021-2030)
  • Table 30: Contrast Media Injectors Market Analysis in the Rest of the World by Region (2021-2030)
  • Table 31: Contrast Media Injectors Market Analysis in the Middle East (2021-2030)
  • Table 32: Contrast Media Injectors Market Analysis in Africa (2021-2030)
  • Table 33: Contrast Media Injectors Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Contrast Media Injectors Market
  • Figure 3: Contrast Media Injectors Market Analysis in Global (2021-2030)
  • Figure 4: Contrast Media Injectors Market Analysis in Global by Product (2021-2030)
  • Figure 5: Contrast Media Injectors Market Analysis in Global by Type of Injectors (2021-2030)
  • Figure 6: Contrast Media Injectors Market Analysis in Global by Application (2021-2030)
  • Figure 7: Contrast Media Injectors Market Analysis in Global by Geography (2021-2030)
  • Figure 8: Contrast Media Injectors Market Analysis in North America (2021-2030)
  • Figure 9: Contrast Media Injectors Market Analysis in North America by Country (2021-2030)
  • Figure 10: Contrast Media Injectors Market Analysis in the US (2021-2030)
  • Figure 11: Contrast Media Injectors Market Analysis in Canada (2021-2030)
  • Figure 12: Contrast Media Injectors Market Analysis in Mexico (2021-2030)
  • Figure 13: Contrast Media Injectors Market Analysis in Europe (2021-2030)
  • Figure 14: Contrast Media Injectors Market Analysis in Europe by Country (2021-2030)
  • Figure 15: Contrast Media Injectors Market Analysis in France (2021-2030)
  • Figure 16: Contrast Media Injectors Market Analysis in Germany (2021-2030)
  • Figure 17: Contrast Media Injectors Market Analysis in the UK (2021-2030)
  • Figure 18: Contrast Media Injectors Market Analysis in Italy (2021-2030)
  • Figure 19: Contrast Media Injectors Market Analysis in Spain (2021-2030)
  • Figure 20: Contrast Media Injectors Market Analysis in the Rest of Europe (2021-2030)
  • Figure 21: Contrast Media Injectors Market Analysis in Asia-Pacific (2021-2030)
  • Figure 22: Contrast Media Injectors Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 23: Contrast Media Injectors Market Analysis in China (2021-2030)
  • Figure 24: Contrast Media Injectors Market Analysis in Japan (2021-2030)
  • Figure 25: Contrast Media Injectors Market Analysis in India (2021-2030)
  • Figure 26: Contrast Media Injectors Market Analysis in Australia (2021-2030)
  • Figure 27: Contrast Media Injectors Market Analysis in South Korea (2021-2030)
  • Figure 28: Contrast Media Injectors Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Figure 29: Contrast Media Injectors Market Analysis in the Rest of the World (2021-2030)
  • Figure 30: Contrast Media Injectors Market Analysis in the Rest of the World by Region (2021-2030)
  • Figure 31: Contrast Media Injectors Market Analysis in the Middle East (2021-2030)
  • Figure 32: Contrast Media Injectors Market Analysis in Africa (2021-2030)
  • Figure 33: Contrast Media Injectors Market Analysis in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Market Opportunities
  • Figure 37: PORTER's Five Force Analysis